Technical Analysis for PROF - Profound Medical Corp.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 1.10% | |
| NR7 | Range Contraction | 1.10% | |
| Narrow Range Bar | Range Contraction | 1.10% | |
| Earnings Movers | Other | 1.10% | |
| BB Squeeze Started | Range Contraction | 1.10% | |
| Gapped Down | Weakness | 1.10% |
| Alert | Time |
|---|---|
| Up 2% | about 22 hours ago |
| 10 DMA Support | about 23 hours ago |
| Rose Above 10 DMA | about 23 hours ago |
| Rose Above Previous Day's High | 1 day ago |
| 10 DMA Resistance | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 10/31/2024
Profound Medical Corp. operates as a medical technology company focuses on magnetic resonance guided ablation procedures in Canada, Germany, and Finland. It is developing a treatment to ablate the prostate gland in prostate cancer patients, treatment of uterine fibroids and nerves, and palliative pain treatment for patients with metastatic bone disease. The company is headquartered in Mississauga, Canada.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Pain Bone Medical Technology Prostate Cancer Interventional Radiology Ablation Magnetic Resonance Nerve Bone Disease Radiofrequency Ablation Fibroids Neoplasms Uterine Fibroid Targeted Radiofrequency Ablation
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Clinical Medicine Pain Bone Medical Technology Prostate Cancer Interventional Radiology Ablation Magnetic Resonance Nerve Bone Disease Radiofrequency Ablation Fibroids Neoplasms Uterine Fibroid Targeted Radiofrequency Ablation
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.66 |
| 52 Week Low | 7.13 |
| Average Volume | 45,679 |
| 200-Day Moving Average | 8.43 |
| 50-Day Moving Average | 7.90 |
| 20-Day Moving Average | 7.51 |
| 10-Day Moving Average | 7.37 |
| Average True Range | 0.26 |
| RSI (14) | 42.53 |
| ADX | 14.25 |
| +DI | 20.82 |
| -DI | 22.82 |
| Chandelier Exit (Long, 3 ATRs) | 7.35 |
| Chandelier Exit (Short, 3 ATRs) | 7.96 |
| Upper Bollinger Bands | 7.86 |
| Lower Bollinger Band | 7.16 |
| Percent B (%b) | 0.27 |
| BandWidth | 9.41 |
| MACD Line | -0.17 |
| MACD Signal Line | -0.18 |
| MACD Histogram | 0.0108 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 7.62 | ||||
| Resistance 3 (R3) | 7.62 | 7.52 | 7.58 | ||
| Resistance 2 (R2) | 7.52 | 7.45 | 7.53 | 7.56 | |
| Resistance 1 (R1) | 7.44 | 7.41 | 7.39 | 7.44 | 7.54 |
| Pivot Point | 7.34 | 7.34 | 7.32 | 7.35 | 7.34 |
| Support 1 (S1) | 7.26 | 7.27 | 7.21 | 7.26 | 7.16 |
| Support 2 (S2) | 7.16 | 7.23 | 7.17 | 7.14 | |
| Support 3 (S3) | 7.08 | 7.16 | 7.13 | ||
| Support 4 (S4) | 7.08 |
